New hope for kids with rare, aggressive cancer after other treatments fail
NCT ID NCT06470464
Summary
This study tested a new combination of drugs for children with a rare and aggressive cancer called yolk sac tumor, which had come back or stopped responding to standard treatments. It combined an older drug, thalidomide, with three chemotherapy drugs to see if it could shrink tumors. The goal was to find a more effective option for these very sick children who had run out of other choices.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERM CELL TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shandong Cancer Hospital and Institute
Jinan, Shandong, 250117, China
Conditions
Explore the condition pages connected to this study.